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IntroduCtIon
Despite the availability of effective treat-
ments and the use of live attenuated vaccines 
in many parts of the world, tuberculosis (TB) 
remains one of the deadliest communica-
ble diseases. Peritoneal TB (PTB) is seen 
in 4.9% of all extrapulmonary TB (ETB) 
cases [1]. Although TB affects the lungs in 
the majority of patients, ETB is the initial 
presentation in approximately 20% of adults, 
and it primarily involves the lymph nodes, 
pleura, and abdomen. ETB occurs more 
commonly in immunosuppressed individu-
als and young children. In those individuals 
with the human immunodeficiency virus 
(HIV), it occurs in more than 50% of the 
cases [1]. Although the Republic of South 
Africa has made notable progress in reduc-
Why Do We Describe This Case
Tuberculosis (TB) has become a global 
problem with the increasing number 
of immunocompromised patients. This 
disease is also spread by overcrowd-
ing, poverty, and drug resistance. The 
abdominal TB rates are rising, and 
the nonspecific features of this type of 
extrapulmonary TB create difficulties 
in establishing a diagnosis. However, 
the prompt initiation of treatment can 
help prevent morbidity and mortality. 
This article should encourage clinicians 
to consider the possibility of abdominal 
TB in the correct clinical setting in order 
to ensure a timely diagnosis and appro-
priate treatment
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Case report
Abstract
Peritoneal tuberculosis (PTB) is a common type of extrapulmonary tuberculosis; however, due 
to variety of clinical presentations, diagnostic challenges do occur. The nonspecific features of this 
disease can lead to diagnostic delays and the development of complications. In addition, PTB 
can mimic a malignancy, especially in women who present with ascites and elevated cancer 
antigen (CA) 125 levels. A high index of suspicion is an important factor in an early diagnosis. 
Moreover, an early diagnosis and the initiation of antituberculous therapy are essential for 
preventing morbidity and mortality. Fortunately, most of these patients respond very well to 
standard antituberculous therapy.
Here, we have reported the case of a young female patient who presented with chronic ascites, mild 
abdominal tenderness, and later, scrofula. Ultimately, she was diagnosed with PTB based on her 
test results. We expect that this case report will contribute to the existing literature on this subject. 
Keywords: Chronic Ascitis; Extrapulmonary Tuberculosis; Ovarian Neoplasms; Peritonitis, 
Tuberculous; Tuberculosis, Lymph Node
CMI 2019; 13(1): 29-34
http://dx.doi.org/10.7175/cmi.v13i1.1416
1 Department of Internal 
Medicine, Pietersburg 
Provincial Hospital, 
Limpopo University, 
Polokwane, South Africa
Galina Bogoslovskaya 1, Jose Zaldivar 1
Peritoneal tuberculosis 
Presenting as Chronic Ascites 
With Scrofula: A Case report
30 Clinical  Management  Issues   2019; 13(1) © 2019 The Authors. Published by SEEd srl. This is an open access article under 
the CC BY-NC 4.0 license (https://creativecommons.org/licenses/by-nc/4.0)
Peritoneal Tuberculosis Presenting as Chronic Ascites With Scrofula: A Case Report
ing the TB prevalence and deaths due to TB, 
as well as improving the treatment outcomes 
for new sputum smear-positive TB cases, the 
TB burden is still enormous [2,3]. 
Ovarian cancer is one of the most diffi-
cult gynecological cancer types to diagnose 
because of its nonspecific symptoms. In 
these cases, PTB is one of the differential 
diagnoses because it can mimic the pattern 
of advanced ovarian cancer while increasing 
the serum markers, such as cancer antigen 
125 (CA125), that are classically associated 
with this cancer type. In a study by Oge et 
al., among 612 patients who underwent sur-
gery for suspected ovarian cancer, 20 of the 
cases (3.2%) were diagnosed postoperatively 
with PTB [4].
Here, we have reported a new case of PTB 
that simulated ovarian cancer.
CASe deSCrIPtIon
A 27-year-old female patient who had a 
normal vaginal delivery six months previ-
ously was referred to the internal medicine 
department for an evaluation of massive 
ascites causing severe abdominal disten-
sion, nausea, vomiting, bloating, and a 
weight gain of 4 kg in five months. She 
had no associated past medical history, 
and her symptoms became progressively 
more severe during the subsequent two 
months. Primarily, she underwent diagnos-
tic testing for ascites by her general prac-
titioner (GP), and it was determined that 
her CA125 level was elevated (428 kU/L; 
the normal limit is 0-35 kU/L). An ex-
ploratory laparotomy was performed by a 
gynecologist based on the suspected diag-
nosis of an ovarian malignancy. However, 
an ovarian malignancy was not found dur-
ing the operation, and a peritoneal biopsy 
was conducted. She was discharged after 
the surgery.
While awaiting the results of the perito-
neal biopsy, this patient experienced pain 
and tenderness in the right side of her neck, 
and she felt a small lymph node in the cer-
vical region. At the same time, she began 
to exhibit a low-grade fever and sweating. 
Based on the above mentioned background 
information, she was referred to the Pieters-
burg Provincial Hospital Internal Medicine 
Department (South Africa) for a diagnostic 
review and admission. 
Upon examination, this patient appeared 
ill but afebrile, with no acute respiratory 
distress (respiratory rate of 18) or unstable 
vital signs. A visual inspection showed a 
single diffuse swollen area of approximately 
4 × 3 cm with ill-defined borders in the right 
cervical region. The overlying skin was the 
same color as the surrounding skin. Upon 
palpation, the mass was slightly tender, fluc-
tuant, compressible, mobile, and showed 
signs of matting (Figure 1). 
However, her other lymph nodes were 
not palpable, her lungs were clear, and her 
cardiovascular examination was normal. Her 
markedly distended abdomen was notable 
for massive ascites with no signs of perito-
nitis. There was mild tenderness in the ab-
domen upon palpation. Moreover, there was 
no lower extremity swelling. The remainder 
of the exam was significant for an unhealed 
Figure 1. Single 
diffuse swollen area of 
approximately 4 × 3 cm 
with ill-defined borders 
in the right cervical 
region.
low laparotomy scar that was oozing a yel-
low-colored fluid. There were no stigmata 
of chronic liver disease or a hernia. She had 
mild anemia, with a hemoglobin level of 11 
g/dL and a normal white blood cell count 
(7.300 × 109/L) and her blood biochemical 
profile was normal. In addition, her viral 
hepatitis test and HIV profile were negative.
Chest radiographs findings did not indi-
cate pulmonary tuberculosis (Figure 2). The 
sputum was negative (GeneXpert®; Ce-
pheid, Sunnyvale, CA, USA). Her abdomi-
nal and thoracic ultrasound revealed massive 
ascites with mild septation. 
At the time of presentation, this patient 
was taking furosemide 40 mg daily and spi-
ronolactone 25 mg daily, which were pre-
scribed by her GP one month before her ad-
mission. We stopped these medications and 
admitted the patient to the medical ward. A 
puncture of the cervical mass resulted in the 
aspiration of 15 ml of yellow turbid liquid 
with marked caseous necrosis. Laparocente-
sis revealed a yellow-color translucent fluid. 
The ascites fluid had a high protein con-
tent, low glucose level, and marked lympho-
cytes with a serum ascites albumin gradient 
(SAAG) lower than 1.1 excluding portal 
hypertension. Furthermore, the ascites fluid 
adenosine deaminase (ADA) levels were 
markedly high (45 U/L; the normal limit 
is < 30 U/L).
The histological examination of the peri-
toneal biopsy revealed numerous caseating 
epithelioid granulomas with multinucleated 
Langhans giant cells lymphocytes, and fo-
cal caseation. Special staining, such as the 
Ziehl-Neelsen stain, identified occasional 
pathological acid-fast bacillus organisms 
that were consistent with TB. Therefore, the 
ovarian malignancy diagnosis was ruled out, 
and PTB with tuberculous lymphadenitis 
was established. Afterwards, patient was 
prescribed the antituberculous treatment 
Rifafour® 3 tablets (each tablet contains: 
rifampicin 150 mg, isoniazid 75 mg, pyra-
zinamide 400 mg, and ethambutol 275 mg) 
[5].Two days after the antituberculous treat-
ment began, the general condition of this 
patient improved significantly, and she was 
discharged from the hospital 10 days after 
her admission to the medical ward. A care-
ful retrospective evaluation of her respiratory 
system showed no evidence of pulmonary 
TB. However, the later results of her ascitic 
fluid culture were positive for Mycobacterium 
tuberculosis. The mycobacterial culture of the 
lymph node aspirate showed negative result.
Figure 2. Chest 
radiographs showing no 
pathological signs.
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low laparotomy scar that was oozing a yel-
low-colored fluid. There were no stigmata 
of chronic liver disease or a hernia. She had 
mild anemia, with a hemoglobin level of 11 
g/dL and a normal white blood cell count 
(7.300 × 109/L) and her blood biochemical 
profile was normal. In addition, her viral 
hepatitis test and HIV profile were negative.
Chest radiographs findings did not indi-
cate pulmonary tuberculosis (Figure 2). The 
sputum was negative (GeneXpert®; Ce-
pheid, Sunnyvale, CA, USA). Her abdomi-
nal and thoracic ultrasound revealed massive 
ascites with mild septation. 
At the time of presentation, this patient 
was taking furosemide 40 mg daily and spi-
ronolactone 25 mg daily, which were pre-
scribed by her GP one month before her ad-
mission. We stopped these medications and 
admitted the patient to the medical ward. A 
puncture of the cervical mass resulted in the 
aspiration of 15 ml of yellow turbid liquid 
with marked caseous necrosis. Laparocente-
sis revealed a yellow-color translucent fluid. 
The ascites fluid had a high protein con-
tent, low glucose level, and marked lympho-
cytes with a serum ascites albumin gradient 
(SAAG) lower than 1.1 excluding portal 
hypertension. Furthermore, the ascites fluid 
adenosine deaminase (ADA) levels were 
markedly high (45 U/L; the normal limit 
is < 30 U/L).
The histological examination of the peri-
toneal biopsy revealed numerous caseating 
epithelioid granulomas with multinucleated 
Langhans giant cells lymphocytes, and fo-
cal caseation. Special staining, such as the 
Ziehl-Neelsen stain, identified occasional 
pathological acid-fast bacillus organisms 
that were consistent with TB. Therefore, the 
ovarian malignancy diagnosis was ruled out, 
and PTB with tuberculous lymphadenitis 
was established. Afterwards, patient was 
prescribed the antituberculous treatment 
Rifafour® 3 tablets (each tablet contains: 
rifampicin 150 mg, isoniazid 75 mg, pyra-
zinamide 400 mg, and ethambutol 275 mg) 
[5].Two days after the antituberculous treat-
ment began, the general condition of this 
patient improved significantly, and she was 
discharged from the hospital 10 days after 
her admission to the medical ward. A care-
ful retrospective evaluation of her respiratory 
system showed no evidence of pulmonary 
TB. However, the later results of her ascitic 
fluid culture were positive for Mycobacterium 
tuberculosis. The mycobacterial culture of the 
lymph node aspirate showed negative result.
Figure 2. Chest 
radiographs showing no 
pathological signs.
dISCuSSIon
PTB can be acute or chronic, and tradi-
tionally, it has been divided into four types:
1. the wet ascitic type is more common, 
and it is associated with a large amount 
of free or loculated fluid in abdomen. The 
ascitic fluid usually exhibits a high den-
sity due to the increased protein content 
of the inflammatory exudate. In addition, 
associated peritoneal enhancement is 
usually present;
2. the dry, fixed, fibrotic type of PTB in-
cludes the involvement of the omentum 
and mesentery, and it is characterized by 
presence of matted bowel loops upon 
imaging. This type of PTB exhibits a 
fibrous peritoneal reaction, peritoneal 
nodules, and the presence of adhesions;
3. occasionally, loculated encysted ascites 
can be present, which constitutes the 
third type of PTB [6,7]. Abdominal co-
coon formation is an uncommon mani-
festation of fibrotic type of PTB that is 
characterized by development of fibrous 
membrane-like sac around of small in-
testine loops. The clinical presentations 
included predominantly abdominal pain 
and intestine obstruction [8];
4. finally, the purulent and rare form of 
PTB usually develops secondarily to 
tuberculous salpingitis, with the pockets 
adherent to the intestine and omentum 
containing TB pus (“cold” abscesses).
However, a combination of these features 
is usually noted [6].
PTB exhibits a diverse and nonspecific 
symptomatology, and no single test is ad-
equate for this diagnosis in all patients 
[7]. Liver cirrhosis, chronic ambulatory 
peritoneal dialysis, diabetes mellitus, and 
HIV are all risk factors for PTB. How-
ever, abdominal TB in a non-HIV patient 
is still a challenging diagnosis requiring 
a high index of clinical suspicion. In this 
particular case, the postpartum condition 
could have been a risk factor for the de-
velopment of ETB, specifically PTB with 
scrofula [9-11].
The extrapulmonary forms of TB con-
stitute approximately one-sixth of all cases, 
and the prevalence of ETB seems to be 
rising, particularly due to the increasing 
prevalence of acquired immunodeficiency 
syndrome. The abdomen is involved in 12% 
of the patients with ETB, and gastrointes-
tinal involvement is found in 66% to 75% 
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of the abdominal cases, with the termi-
nal ileum and ileocecal regions being the 
most common sites of involvement. This 
frequency is higher, and it could double or 
even triple, in HIV-positive subjects. ETB 
can affect all age groups, with a predilection 
for women between 20 and 50 years of age 
[9]. The peritoneal transplantation of M. tu-
berculosis is hematogenous, and it is mainly 
transplanted from primary infections that 
often go unnoticed. More rarely, it can be 
transplanted after a first gastrointestinal in-
fection. In other cases, the peritoneal infec-
tion represents seeding from the abdominal 
lymph nodes [12].
Clinically, PTB can mimic advanced 
ovarian cancer, with pelvic pain, abdominal 
distension, weight loss, and palpation of an 
abdominopelvic mass being present in both 
conditions. However, the search for and ab-
sence of other signs, such as menstrual disor-
ders (55% of the cases) and infertility (5% to 
10% of the cases), can be useful for the diag-
nosis of abdominal TB [13]. An association 
with other localizations, especially pulmo-
nary, should be investigated, but its absence 
does not eliminate the diagnosis of PTB, 
as in our case. Several imaging techniques, 
such as ultrasonography and computed to-
mography, can sometimes guide the diag-
nosis. The existence of ascites with septas, 
peritoneal thickening, and heterogeneous 
enhancement are typical for inflammatory 
processes like TB. In addition, the CA125 
level, which is an ovarian cancer biomarker 
of epithelial origin, can be high in several 
benign gynecological diseases (endometri-
osis, uterine fibroids, and pelvic inflamma-
tory processes), extragynecological diseases 
(peritonitis, pancreatitis, hepatitis, nephrotic 
syndrome, and PTB), and nongynecological 
cancers with peritoneal metastases. In PTB 
cases, very high CA125 values (> 1,000 U/
mL) can be seen [14]. Moreover, 90.1% of 
PTB patient have elevated plasma CA125 
levels with a mean value of 565 U/mL [13]. 
Therefore, CA125 has no place in the dif-
ferential diagnosis between ovarian cancer 
and PTB. However, a decrease in the CA125 
level has been correlated with the TB treat-
ment response, and it has been indicated 
as a surveillance marker in antituberculous 
therapy [14].
Ascitis may be the first manifestation of 
a systemic disease or an otherwise unsus-
pected abdominal disease. In most cases, 
ascitis appears as part of a well-recognized 
illness, e.g. cirrhosis, congestive heart failure, 
nephrosis, or disseminated carcinomatosis. 
Occasionally, it may develop as an isolated 
finding in the absence of a clinically evident 
disease. In such cases, a thorough analysis of 
the ascitic fluid helps identify the etiology 
[11]. For instance, a SAAG value of > or < 1 
g/dL can differentiate between a transudate 
and an exudate fluid. A SAAG value of > 1 
is usually related to uncomplicated cirrhosis, 
alcoholic hepatitis, congestive heart failure, 
and Budd-Chiari syndrome, while a SAAG 
value of < 1 is related to other causes, such 
as peritoneal carcinomatosis, tuberculous 
peritonitis, pancreatitis, serositis, pyogenic 
peritonitis, and nephritic syndrome. A cer-
tain diagnosis via an ascitic fluid analysis is 
made only after the detection of M. tuber-
culosis using either a direct examination or 
after a Lowenstein-Jensen medium culture. 
The ascitic fluid ADA ratio was also higher 
in patients with peritoneal tuberculosis than 
with other causes of ascites. ADA is useful 
diagnostic test for establishment of tuber-
culosis [15]. At present, an ascites ADA 
activity of 30 U/L is generally accepted as 
the cut-off level expected to yield the best 
results [16,17]. Tissue Xpert™ MTB/Rif is 
of limited use in diagnosis of peritoneal TB 
[18]. The other laboratory tests results are 
nonspecific, including mild anemia, inflam-
matory biomarker elevations, and an intra-
dermal reaction to tuberculin [19]. However, 
serum C reactive protein (CRP) is a very 
useful tool in the assessment of response to 
anti-tubercular therapy in abdominal tuber-
culosis [20].
In our case, the anatomopathological 
examination after the caseous granulation 
biopsy was sufficient to confirm the diag-
nosis. In addition, the search for mycobac-
teria using polymerase chain reaction can 
be useful for the diagnosis, with a sensitiv-
ity of 75-80% and a specificity of 85-95%, 
but this technique is often unavailable in 
South African hospitals. As in the case of 
our patient, surgical exploration is neces-
sary to confirm or rule out the suspicion of 
a malignant ovarian tumor. The first route 
can consist of either a laparotomy or lapa-
roscopy. However, transvaginal or transab-
dominal ultrasound-guided biopsies can be 
used in cases with a strong suspicion of TB, 
thus limiting postoperative complications 
[19,21]. The histological study of biopsies 
makes it possible to correct the diagnosis 
by showing gigantocellular granulomas 
with caseous necrosis specific for Koch’s 
bacillus. The treatment of PTB is essen-
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tially medical, and it is based on the daily 
administration of a quadritherapy com-
bining isoniazid, rifampicin, ethambutol, 
and pyrazinamide for two months. Then, 
a four-month maintenance treatment is 
begun, using daily dual therapy combining 
isoniazid and rifampicin [5]. Steroids may 
be of benefit in peritonitis, but the evidence 
is scant and the routine use of steroids can-
not be recommended [22].
A surgical procedure is especially indi-
cated in cases with a compressive, obstruc-
tive or fistulised mass in order to flatten the 
caseous cavities [5,23].
Overall, PTB prevention is based on a Ba-
cillus Calmette-Guérin vaccination, the de-
tection of asymptomatic and atypical forms, 
chemoprophylaxis in the case of contact, and 
improvements in the hygiene of populations 
at risk [23].
ConCluSIon
Here we reported a case of postpar-
tum PTB mimicking a malignant tumor. 
A 27-year-old woman who had a normal 
vaginal delivery six months previously pre-
sented to our department with ascites and 
an elevated serum CA125 level. PTB was 
diagnosed via a peritoneal biopsy. After 
undergoing treatment using the four-drug 
anti-TB regimen including isoniazid, rifam-
picin, ethambutol, and pyrazinamide, the 
patient recovered with the disappearance 
of ascites and a normal CA125 serum level 
after six months. These findings may lead to 
a misdiagnosis of ovarian cancer. This case 
emphasizes the fact that tuberculosis peri-
tonitis should be considered as a differential 
diagnosis of ovarian cancer metastasis in 
patients with elevated serum CA125 values.
Key Points
 y Tuberculosis (TB) can spread from the lungs and lymph nodes through the bloodstream to 
many sites, including the abdomen, particularly the peritoneum
 y The TB symptoms depend on the affected organ, but they may be very atypical and nonspecific
 y CA125, an ovarian cancer biomarker, can be elevated in PTB cases
 y The diagnosis of PTB is based on the identification of M. tuberculosis in the infected fluid 
or a microscopic examination of the peritoneal tissue and culture
 y A decrease in the CA125 level is correlated with the TB treatment response
 y In patients with peritoneal tuberculosis the ascitic fluid and serum ADA activity was sig-
nificantly higher than for other types of ascites
 y Serum CRP remains very useful tool in the assessment of response to anti-tubercular 
therapy in abdominal tuberculosis
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